Ingrezza 80 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5T7V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,245
Award facts
- Contract value 100% obligated
- $4,244.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,244.58 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count packaging). This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. INGREZZA (valbenazine) is an FDA-approved medication used to treat tardive dyskinesia, a neurological movement disorder, reflecting the pharmaceutical distributor's role in supplying specialized therapeutic medications to support federal healthcare programs.
This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling value through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency, supplying pharmaceuticals and medical supplies across multiple therapeutic domains to support military healthcare systems and other federal healthcare entities. The company's federal contracting history demonstrates consistent capability to deliver diverse medical commodities ranging from specialty medications to generic drugs and medical devices.
Quick answers
Who was awarded contract SPE2DR26F5T7V?
SPE2DR26F5T7V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F5T7V worth?
The government has obligated $4,245 on SPE2DR26F5T7V.
Is contract SPE2DR26F5T7V an order under another contract?
Yes. SPE2DR26F5T7V is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5T7V competed?
The extent of competition for SPE2DR26F5T7V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award